Virtual Reality + Olfactory Intervention for Postoperative Pain and Anxiety
Trial Summary
What is the purpose of this trial?
This trial tests if using virtual reality and pleasant smells can help reduce pain and anxiety in patients having heart or lung surgery. The treatment aims to offer a safer alternative to traditional medications like opioids. Patients will use VR headsets and scented necklaces to see if it helps them feel better. Virtual reality (VR) has been studied as an effective non-drug method for pain and anxiety management in various medical conditions and procedures.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. It seems you may continue your usual medical care, but it's best to confirm with the trial coordinators.
What data supports the effectiveness of the treatment Virtual Reality and Olfactory Stimuli Therapy for postoperative pain and anxiety?
Is the combination of virtual reality and olfactory stimuli safe for reducing pain and anxiety?
Research on virtual reality (VR) for reducing pain and anxiety shows it is generally safe, with no significant side effects reported. Studies have found VR helpful in reducing anxiety and pain during medical procedures, and it is considered a promising non-drug option for managing these symptoms.12678
How is the VR/OS Multimodal Intervention treatment different from other treatments for postoperative pain and anxiety?
The VR/OS Multimodal Intervention is unique because it combines virtual reality (VR) with olfactory stimuli (smell-based therapy) to manage postoperative pain and anxiety, offering a non-drug approach that uses immersive experiences to distract and alter perception of pain. This treatment is novel as it leverages both visual and olfactory senses to enhance the therapeutic effect, potentially reducing the need for traditional pain medications like opioids.1791011
Research Team
Eligibility Criteria
Adults over 18 scheduled for certain cardiothoracic surgeries (like bypass grafting or lung resection) can join, except those with severe heart, kidney, liver issues, odor allergies, anosmia or cognitive/psychiatric conditions affecting consent.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-Surgery Intervention
Participants receive the first virtual reality and olfactory stimuli therapy session approximately 2-4 weeks before surgery
Surgery and Immediate Pre-Surgery Intervention
Participants receive a virtual reality and olfactory stimuli session 90 minutes before surgery
Post-Surgery In-Hospital Recovery
Participants receive daily virtual reality and olfactory stimuli sessions in the afternoon and nighttime olfactory stimulation during in-hospital recovery
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Virtual Reality and Olfactory Stimuli Multimodal Intervention (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
Dr. William Curry
Massachusetts General Hospital
Chief Medical Officer
MD from Harvard Medical School
Dr. Anne Klibanski
Massachusetts General Hospital
Chief Executive Officer since 2019
MD from Harvard Medical School